| Patents for A61P 43 - Drugs for specific purposes, not provided for in groups (156,317) |
|---|
| 04/10/2002 | EP1194156A1 Method of treating malignancies and viral infections and improving immune function with a dietary supplement |
| 04/10/2002 | EP1194152A1 Src kinase inhibitor compounds |
| 04/10/2002 | EP1194151A1 Integrin receptor antagonists |
| 04/10/2002 | EP1194147A1 Arylthiazolidinedione and aryloxazolidinedione derivatives |
| 04/10/2002 | EP1194143A2 Il-8 receptor antagonists |
| 04/10/2002 | EP1194142A1 Salts of cis -4-cyano-4-(3-cyclopentyloxy-4-methoxyphenyl) cyclohexan-1-carboxylate! |
| 04/10/2002 | EP1194138A1 Nutritional supplements |
| 04/10/2002 | EP1194135A2 Methods of treating fungal infections with inhibitors of nad synthetase enzyme |
| 04/10/2002 | EP1194126A1 Dry powder compositions |
| 04/10/2002 | EP1194115A1 Topically applied idebenone-containing agent with protective and regenerative effect |
| 04/10/2002 | EP1087986B1 7.alpha.-methyl 19-nortestosterone undecanoate with androgenic activity |
| 04/10/2002 | EP1051159B1 Solid pharmaceutical compositions containing miltefosine for oral administration in the treatment of leishmaniasis |
| 04/10/2002 | EP1042323B1 Novel camptothecin tetracyclic analogues, preparation, methods, applications as medicines and pharmaceutical compositions containing them |
| 04/10/2002 | EP1030845B1 Heterocyclic compounds having mmp and tnf inhibitory activity |
| 04/10/2002 | EP1024822B1 Cd8 as an inhibitor of the cellular immune system |
| 04/10/2002 | EP1021172B1 Dosage form for aerosol administration |
| 04/10/2002 | EP0948478B1 ARYL OR HETEROARYL SUBSTITUTED 3,4-DIHYDROANTHRACENE AND ARYL OR HETEROARYL SUBSTITUTED BENZO[1,2-g]-CHROM-3-ENE, BENZO[1,2-g]-THIOCHROM-3-ENE AND BENZO[1,2-g]-1,2-DIHYDROQUINOLINE DERIVATIVES HAVING RETINOID ANTAGONIST OR RETINOID INVERSE AGONIST TYPE BIOLOGICAL ACTIVITY |
| 04/10/2002 | EP0936911B1 Adenosine deaminase inhibitors |
| 04/10/2002 | EP0930885B1 The use of heparin or heparan sulphate in combination with chitosan for the prevention or treatment of infections caused by herpes virus |
| 04/10/2002 | EP0912567B1 Carboline derivatives |
| 04/10/2002 | EP0874842B1 Mercaptoalkylpeptidyl compounds having an imidazole substituent and their use as inhibitors of matrix metalloproteinases (mmp) and/or tumour necrosis factor (tnf) |
| 04/10/2002 | EP0788383B1 Modulation of cell proliferation and wound healing |
| 04/10/2002 | EP0739351B1 Monomeric diols and phosphate linked oligomers formed therefrom |
| 04/10/2002 | EP0739338B1 serine protease inhibitors: derivatives of isothiazolidin-3-one-1,1 dioxide and 3-oxo-1,2,5-thiadiazolidine-1,1-dioxide |
| 04/10/2002 | EP0694070B1 Recombinant alphavirus vectors |
| 04/10/2002 | EP0661990B1 Method for systemic treatment of catabolic conditions and systemic tissue injury |
| 04/10/2002 | CN1344326A Petroviral vectors comprising functional and non-functional splice donor and splce acceptor sites |
| 04/10/2002 | CN1344317A 多肽 Polypeptide |
| 04/10/2002 | CN1344315A Improved phytases |
| 04/10/2002 | CN1344287A Ionic molecular conjugates of biodegradable polyesters and bioactive polypeptides |
| 04/10/2002 | CN1344271A Remedies |
| 04/10/2002 | CN1344268A Use of imidazo [1,5-a]pyrido[3,2-e]-pyrazinones as medicaments |
| 04/10/2002 | CN1344266A Novel compounds |
| 04/10/2002 | CN1344265A Piperidine, tetrahydropyridine and piperazine derivatives, their prepn. and use |
| 04/10/2002 | CN1344264A Tetrahydropyran derivatives and their use as therapeutic agents |
| 04/10/2002 | CN1344257A Fused pydiopyridazine inhibitors of cGMP phosphodiesterase |
| 04/10/2002 | CN1344256A (Hetero) aryl-bicyclic heteroaryl derivatives, their prepn. and their use as protease inhibitors |
| 04/10/2002 | CN1344250A 间苯二酚衍生物 Resorcinol derivatives |
| 04/10/2002 | CN1344249A 酰胺衍生物 Amide derivatives |
| 04/10/2002 | CN1344245A Branched chain amino acid-dependent aminotransferase inhibitors and their use in treatment of diabetic retinopathy |
| 04/10/2002 | CN1344164A Method of treatment of equine disease |
| 04/10/2002 | CN1344163A Stabilized oral pharmaceutical compsn. contg. iodide and iodate and method |
| 04/10/2002 | CN1344162A Medical compsns. |
| 04/10/2002 | CN1344161A Use of pyridazino [4,5-i(b)]indole-1-acetamide derivatives for preparing medicines for treating disease related to dysfunction of peripheral benzodiazepin receptors |
| 04/10/2002 | CN1344157A Use of certain offinity NMDA antagonists as antidepressants |
| 04/10/2002 | CN1344155A Transnasal transport/immunisation with highly adaptable carriers |
| 04/10/2002 | CN1344152A Resorcinol compsn. |
| 04/10/2002 | CN1344135A Organ arrest, protection and preservation |
| 04/10/2002 | CN1343516A Medicine for nourishing liver, kidney and hair and beautifying face and its preparing process |
| 04/10/2002 | CN1082371C NK-1 receptor antagonist and 5HT3 receptor antagonists for treating emesis |
| 04/09/2002 | US6369273 Chemical compounds and their use to elevate pyruvate dehydrogenase activity |
| 04/09/2002 | US6369236 Imidazole derivatives with biphenylsulfonyl substitution method for preparing them and their use as a drug or diagnostic agent |
| 04/09/2002 | US6369235 Inhibitors of hiv reverse transcription for treatment of aids |
| 04/09/2002 | US6369229 Pyridylalanine derivatives |
| 04/09/2002 | US6369226 Substituted benzamide inhibitors of rhinovirus 3C protease |
| 04/09/2002 | US6369224 Spiroazabicyclic heterocyclic amine borane complexes; psychological, nervous system and brain disorders; anxiolytic agents, antidepressants, analgesics; alzheimer*s and parkinson*s disease; smoking cessationa |
| 04/09/2002 | US6369221 Anticonvulsants, antiischemic agents; brain and nervous system disorder treatment |
| 04/09/2002 | US6369210 22012, human carboxypeptidase |
| 04/09/2002 | US6369209 Oligonucleotides having A-DNA form and B-DNA form conformational geometry |
| 04/09/2002 | US6369201 For increasing muscle synthesis and treating disease in vertebrate subjects, for reducing myostatin activity |
| 04/09/2002 | US6369193 Contulakin-G, analogs thereof and uses therefor |
| 04/09/2002 | US6369107 Combined use of diclofenac and tribenoside to treat osteoarthritis |
| 04/09/2002 | US6369103 Hmg coa reductase inhibitor such as pravastatin to a patient which has one or more risk factors for a coronary and/or cerebrovascular event such as hypercholesterolemia |
| 04/09/2002 | US6369102 Glaucoma |
| 04/09/2002 | US6369100 Method for inhibiting gene expression promoted by AP1 protein with RARβ selective retinoids and method for treatment of diseases and conditions with such retinoids |
| 04/09/2002 | US6369096 Benzyloxy prodigiosine compounds |
| 04/09/2002 | US6369094 3-(n-methyl-2(r)-pyrrolidinylmethyl)-5-(2-phenylsulphonylethyl )-1h-indole, analgesic for migrane |
| 04/09/2002 | US6369089 Interheteroaryl 7-oxabicyclic [2.2.1]heptane oxazoles as prostaglandin F2α antagonists |
| 04/09/2002 | US6369088 Substituted 3-phenyl-5-alkoxy-1,3,4-oxadiazol-2-ones, their preparation and their use as pharmaceuticals |
| 04/09/2002 | US6369086 Substituted oxidole derivatives as protein tyrosine and as protein serine/threonine kinase inhibitors |
| 04/09/2002 | US6369079 Methods for treating irritable bowel syndrome using optically pure (+) norcisapride |
| 04/09/2002 | US6369077 Protease inhibitors |
| 04/09/2002 | US6369075 7[4′-trifluoromethyl-biphenyl-2-carbonyl)amino]-quinoline-3-carboxylic acid amides, and method of inhibiting the secretion of apolipoprotein B |
| 04/09/2002 | US6369073 Compounds having reversible inhibiting activity of carnitine palmitoyl-transferase |
| 04/09/2002 | US6369070 Methods for inhibiting mrp1 |
| 04/09/2002 | US6369069 Cardiovascular disorders |
| 04/09/2002 | US6369065 CD40 signal blocking agent |
| 04/09/2002 | US6369060 Central nervous system disorders such as anxiety; 5-methyl-6-trifluoromethyl-1-(6-(2-methylpyridin-3-yloxy)-pyridin-3-yl carbamoyl)indoline and 5-methyl-1-(6-(2-methylpyridin-3-yloxy) -pyridazin-3-ylcarbamoyl)-6-trifluoromethylindoline |
| 04/09/2002 | US6369059 Tetracyclic derivatives, process of preparation and use |
| 04/09/2002 | US6369049 Treatment of mastitis |
| 04/09/2002 | US6369046 Administration of a glucocorticoid receptor antagonist, mifepristone |
| 04/09/2002 | US6369039 Saturated solution; catheter |
| 04/09/2002 | US6369034 For therapy of cancer, restenosis, and atherosclerosis |
| 04/09/2002 | US6369032 Method for treating allergies |
| 04/09/2002 | US6369029 Method of stimulating osteogenesis using a c-terminally truncated insulin-like growth factor binding protein-5 (IGFBP-5) |
| 04/09/2002 | US6369027 Osteoprotegerin |
| 04/09/2002 | US6368853 A nucleic acid encoding a polypeptide ligand; tyrosine kinase containing immunoglobulin and epidermal growth factor homolog domains; therapy and diagnosis for angiogenesis in wound healing, inflammation or tumors |
| 04/09/2002 | US6368852 A peptide capable of inducing cytotoxic t lymphocytes, immune response; anticarcinogenic agents |
| 04/09/2002 | US6368829 An isolated nucleic acid encoding a polypeptide for a tumor suppressor gene; diagnosis and therapy for diseases |
| 04/09/2002 | US6368789 Screening methods to identify inhibitors of telomerase activity |
| 04/09/2002 | US6368787 Methods and compositions for identifying morphogenic protein analogs using morphogenic protein responsive inhibitory elements |
| 04/09/2002 | US6368636 Mesenchymal stem cells for prevention and treatment of immune responses in transplantation |
| 04/09/2002 | US6368603 Immunological composition; mixture of antigens |
| 04/09/2002 | US6368597 Methods of treating diabetes |
| 04/09/2002 | US6368594 Pure polypeptide |
| 04/09/2002 | US6368580 Gastrointestinal disorders; oral administering bacillus |
| 04/09/2002 | CA2229000C 1-biphenylimidazole derivatives, their preparation and their therapeutic use |
| 04/09/2002 | CA2215732C Quinazoline derivatives |
| 04/09/2002 | CA2184886C Method of strengthening antibacterial action of antibiotics |
| 04/09/2002 | CA2071224C Quinoline derivatives, their production and use |